Corpus overview


MeSH Disease

Human Phenotype


    displaying 1 - 3 records in total 3
    records per page

    Autoantibody-negative insulin-dependent Diabetes MESHD after COVID-19

    Authors: Tim Hollstein; Juliane Schulz; Andreas Glück; Dominik M Schulte; Stefan Schreiber; Stefan R Bornstein; Matthias Laudes

    doi:10.21203/ Date: 2020-07-01 Source: ResearchSquare

    Here we report the manifestation of insulin dependent diabetes MESHD after a COVID-19 infection MESHD in the absence of typical autoantibodies for type 1 diabetes MESHD. A 19-year-old Caucasian male TRANS subject presented to our emergency department with diabetic ketoacidosis HP diabetic ketoacidosis MESHD ( DKA MESHD). C-peptide levels accounted to 0.62µg/L in the presence of blood SERO glucose concentrations of 30.6 mmol/L (552 mg/dL). The patient´s case history revealed a COVID-19 disease 6-8 weeks prior to admission. This is of interest, since COVID-19 internalization into host cells is mediated via Angiotensin-converting enzyme 2 (ACE2) [1], a transmembrane glycoprotein which amongst others is crucial for β-cell homeostasis and function [2,3,4]. Detailed laboratory testing was performed, revealing no serum SERO- antibodies SERO against islet-cells (ICA), glutamic acid decarboxylase (GAD65-AA), tyrosine phosphatase (IA-2-AA), insulin (IAA) and zinc-transport-8 (ZnT8-AA), but against COVID-19. Hence, this is a presentation of an insulin-dependent diabetes mellitus MESHD diabetes mellitus HP in the absence of markers of autoimmunity HP, which might suggest direct cytolytic effects of COVID-19 on pancreatic β-cells presumably mediated via ACE2.

    Missing during COVID-19 lockdown: children TRANS with new-onset type 1 diabetes MESHD

    Authors: Devi Dayal; Saniya Gupta; Dhvani Raithatha; Muralidharan Jayashree

    doi:10.21203/ Date: 2020-05-12 Source: ResearchSquare

    The redistribution of healthcare resources for coronavirus 2019 (COVID-19) pandemic has resulted in unintentional neglect of essential non-COVID-19 care (1). In low- and lower-middle income countries (LMIC), the already overstretched healthcare systems have crumbled under the COVID-19 pressure (2). Additionally, hardline lockdown restrictions, and fear of exposure to severe acute respiratory syndrome coronavirus 2 MESHD (SARS-CoV-2) in healthcare settings have forced patients with non-COVID-19 illnesses to stay home and suffer until their illness deteriorates substantially, and sometimes irreversibly.  The impact of COVID-19 on the pediatric population has so far been mild, except in children TRANS with comorbidities (3). However, children TRANS who develop new time-sensitive non-COVID-19 illnesses during the pandemic are at risk of worsening or death MESHD due to compromised access to hospital care. In particular, children TRANS with new-onset type 1 diabetes MESHD (T1D) may progress rapidly to diabetic ketoacidosis HP diabetic ketoacidosis MESHD ( DKA MESHD) if treatment with insulin is delayed, and are therefore at risk of increased morbidity and mortality. 

    Near-fatal experience due to delayed diagnosis of type 1 diabetes MESHD during the COVID-19 pandemic

    Authors: Devi Dayal; Saniya Gupta; Dhvani Raithatha; Prakash Soni; Surjeet Thapa; Arun Baranwal

    doi:10.21203/ Date: 2020-04-25 Source: ResearchSquare

    The focus of national governments and the medical profession on the pandemic of coronavirus disease MESHD 2019 (COVID-19) has resulted in neglect of care for children TRANS with new onset illnesses. Type 1 diabetes MESHD (T1D), the most common endocrine disorder MESHD in children TRANS, is prone to rapid deterioration if not diagnosed in time. We recently encountered a child TRANS who presented in a critical condition and was later diagnosed to have diabetic ketoacidosis HP diabetic ketoacidosis MESHD. We discuss the circumstances arising out of the severe lockdown restrictions for COVID-19, which resulted in difficulties in accessing the healthcare services and caused significant delay in the diagnosis of T1D and a near-death experience. It is essential to keep the non-COVID healthcare services open for children TRANS with new onset illnesses and those with chronic conditions for timely access in order to reduce morbidity and mortality due to these conditions.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
Human Phenotype

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.